Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to -$0.06.

  • Lifecore Biomedical, Inc. \De\'s EPS (Weighted Average and Diluted) rose 6905.79% to -$0.06 in Q2 2025 from the same period last year, while for May 2025 it was -$1.27, marking a year-over-year decrease of 70666.28%. This contributed to the annual value of -$1.27 for FY2025, which is 48605.81% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s EPS (Weighted Average and Diluted) is -$0.06, which was up 6905.79% from -$0.47 recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s EPS (Weighted Average and Diluted) peaked at $0.42 during Q1 2024, and registered a low of -$1.75 during Q2 2022.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median EPS (Weighted Average and Diluted) value was -$0.34 (recorded in 2021), while the average stood at -$0.41.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s EPS (Weighted Average and Diluted) crashed by 236232.9% in 2022 and then skyrocketed by 19069.77% in 2023.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s EPS (Weighted Average and Diluted) stood at -$1.31 in 2021, then surged by 67.18% to -$0.43 in 2022, then soared by 190.7% to $0.39 in 2023, then tumbled by 164.1% to -$0.25 in 2024, then soared by 76.48% to -$0.06 in 2025.
  • Its last three reported values are -$0.06 in Q2 2025, -$0.47 for Q1 2025, and -$0.25 during Q4 2024.